References
- Schwarz KB. Oxidative stress during viral infection: a review. Free Radic Biol Med 1996; 21: 641–9
- Peterhans E. Oxidants and antioxidants in viral diseases: disease mechanisms and metabolic regulation. J Nutr 1997; 127: S962–5
- Beck MA, Shi Q, Morris VC, Levander OA. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Med 1995; 1: 433–6
- De Maria N, Colantoni A, Fagiuoli S, Liu G-J, Rogers BK, Farinati F, et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996; 21: 291–5
- Boya P, Pena A, Beloqui O, Larrea E, Conchillo M, Castelruiz Y, et al. Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C. J Hepatol 1999; 31: 808–14
- Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA. Mitochondrial injury, oxidative stress and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002; 122: 366–75
- Jain SK, Pemberton PW, Smith A, McMahon RFT, Burrows PC, Aboutwerat A, Warnes TW. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol 2002; 36: 805–11
- Yadav D, Hertan HI, Schweitzer P, Norkus EP, Pitchumoni CS. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. Am J Gastroenterol 2002; 97: 2634–9
- Friis H, Gomo E, Kæstel P, Ndhlovu P, Nyazema N, Krarup H, Michaelsen KF. HIV and other predictors of serum β-carotene and retinol in pregnancy: a cross-sectional study in Zimbabwe. Am J Clin Nutr 2001; 73: 1058–65
- Lykkesfeldt J, Loft S, Poulsen HE. Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with colorometric detection: are they reliable biomarkers of oxidative stress?. Anal Biochem 1995; 229: 329–35
- Krarup HB, Drewes AM, Madsen PH. A quantitative HCV-PCR test for routine diagnostics. Scand J Lab Invest 1998; 58: 415–22
- Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004; 351: 23–32
- Look MP, Gerard A, Rao GS, Sudhop T, Fischer H-P, Sauerbruch T, Sprengler U. Interferon/antioxidant combination therapy for chronic hepatitis C: a controlled pilot trial. Antiviral Res 1999; 43: 113–22
- Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358: 958–65
- Hézode C, Lonjon I, Roudot-Thoraval F, Mavier J-P, Pawlotsky J-M, Zafrani ES, Dhumeaux D. Impact of smoking on histological liver lesion in chronic hepatitis C. Gut 2003; 52: 126–9